Previous Article | Next Article 
Journal of Clinical Microbiology, November 2002, p. 4105-4113, Vol. 40, No. 11
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.11.4105-4113.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Human Cytomegalovirus DNA in Plasma and Serum Specimens of Renal Transplant Recipients Is Highly Fragmented
René Boom,1 Cees J. A. Sol,1 Tim Schuurman,1 Alex van Breda,1 Jan F. L. Weel,1 Marcel Beld,1 Ineke J. M. ten Berge,2 Pauline M. E Wertheim-van Dillen,1 and Menno D. de Jong1*
Section of Clinical Virology, Department of Medical Microbiology,1
Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2
Received 27 December 2001/
Returned for modification 23 March 2002/
Accepted 4 August 2002
Quantitation of cytomegalovirus (CMV) DNA in plasma and serum by PCR is increasingly used to identify patients at risk for developing CMV disease and to monitor the efficacy of antiviral therapy. Although CMV DNA levels are generally interpreted as viral loads, the exact nature of the viral DNA in these specimens is unknown. We studied the state of CMV DNA in plasma and serum specimens obtained from three renal transplant recipients at peak viral DNA levels during primary CMV infection. For this purpose, DNA isolated from these specimens was fractionated by size, and CMV DNA levels in the resulting DNA fractions were measured by quantitative PCR targeted at large (578-bp) and small (134-bp) amplicons. These experiments showed that the molecular sizes of DNA fragments from which CMV DNA is amplified were small (<2,000 bp), indicating that CMV DNA in plasma and serum is highly fragmented. Furthermore, CMV DNA levels were consistently higher when targeted at the smaller amplicon, providing additional evidence for the fragmentation of viral DNA. In conclusion, the first results with three patients have shown that CMV DNA in plasma and serum is highly fragmented and does not necessarily reflect the amount of infectious virus. These observations have potential consequences for understanding CMV pathogenesis and interpreting CMV DNA levels in individual patient management.
* Corresponding author. Mailing address: Department of Medical Microbiology, Academic Medical Center, L1-103, University of Amsterdam, Postbox 22660, 1100 DD Amsterdam, The Netherlands. Phone: (31)-20-5663026. Fax: (31)-20-5669745. E-mail:
m.d.dejong{at}amc.uva.nl.
Journal of Clinical Microbiology, November 2002, p. 4105-4113, Vol. 40, No. 11
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.11.4105-4113.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Habbal, W., Monem, F., Gartner, B. C.
(2009). Comparative evaluation of published cytomegalovirus primers for rapid real-time PCR: which are the most sensitive?. J Med Microbiol
58: 878-883
[Abstract]
[Full Text]
-
Fafi-Kremer, S., Morand, P., Barranger, C., Bargues, G., Magro, S., Bes, J., Bourgeois, P., Joannes, M., Seigneurin, J.-M.
(2008). Evaluation of the Epstein-Barr Virus R-Gene Quantification Kit in Whole Blood with Different Extraction Methods and PCR Platforms. J. Mol. Diagn.
10: 78-84
[Abstract]
[Full Text]
-
Schuurman, T., van Breda, A., de Boer, R., Kooistra-Smid, M., Beld, M., Savelkoul, P., Boom, R.
(2005). Reduced PCR Sensitivity Due to Impaired DNA Recovery with the MagNA Pure LC Total Nucleic Acid Isolation Kit. J. Clin. Microbiol.
43: 4616-4622
[Abstract]
[Full Text]
-
Stevens, S. J. C., Verkuijlen, S. A. W. M., Hariwiyanto, B., Harijadi, , Fachiroh, J., Paramita, D. K., Tan, I. B., Haryana, S. M., Middeldorp, J. M.
(2005). Diagnostic Value of Measuring Epstein-Barr Virus (EBV) DNA Load and Carcinoma-Specific Viral mRNA in Relation to Anti-EBV Immunoglobulin A (IgA) and IgG Antibody Levels in Blood of Nasopharyngeal Carcinoma Patients from Indonesia. J. Clin. Microbiol.
43: 3066-3073
[Abstract]
[Full Text]
-
Kalpoe, J. S., Kroes, A. C. M., de Jong, M. D., Schinkel, J., de Brouwer, C. S., Beersma, M. F. C., Claas, E. C. J.
(2004). Validation of Clinical Application of Cytomegalovirus Plasma DNA Load Measurement and Definition of Treatment Criteria by Analysis of Correlation to Antigen Detection. J. Clin. Microbiol.
42: 1498-1504
[Abstract]
[Full Text]
-
Boeckh, M., Huang, M., Ferrenberg, J., Stevens-Ayers, T., Stensland, L., Nichols, W. G., Corey, L.
(2004). Optimization of Quantitative Detection of Cytomegalovirus DNA in Plasma by Real-Time PCR. J. Clin. Microbiol.
42: 1142-1148
[Abstract]
[Full Text]
-
Nesbitt, S. E., Cook, L., Jerome, K. R.
(2004). Cytomegalovirus Quantitation by Real-Time PCR Is Unaffected by Delayed Separation of Plasma from Whole Blood. J. Clin. Microbiol.
42: 1296-1297
[Abstract]
[Full Text]
-
Schuurman, T., de Boer, R. F., Kooistra-Smid, A. M. D., van Zwet, A. A.
(2004). Prospective Study of Use of PCR Amplification and Sequencing of 16S Ribosomal DNA from Cerebrospinal Fluid for Diagnosis of Bacterial Meningitis in a Clinical Setting. J. Clin. Microbiol.
42: 734-740
[Abstract]
[Full Text]
-
Leruez-Ville, M., Ouachee, M., Delarue, R., Sauget, A.-S., Blanche, S., Buzyn, A., Rouzioux, C.
(2003). Monitoring Cytomegalovirus Infection in Adult and Pediatric Bone Marrow Transplant Recipients by a Real-Time PCR Assay Performed with Blood Plasma. J. Clin. Microbiol.
41: 2040-2046
[Abstract]
[Full Text]